Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00000940
First received: November 2, 1999
Last updated: January 5, 2016
Last verified: January 2016